Evidence map›Paper›PMID 40338665›Full record

ArticleJCI insight2025

Multiomics analysis unveils an inosine-sensitive DNA damage response in neurogenic bladder after spinal cord injury.

Ali Hashemi Gheinani, Bryan S Sack, Alexander Bigger-Allen, Hatim Thaker, Hussein Atta, George Lambrinos, Kyle Costa, Claire Doyle, Mehrnaz Gharaee-Kermani, Susan Patalano and 12 more

Abstract read
In one paragraph

Article in JCI insight, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Ali Hashemi GheinaniUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Bryan S SackUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Alexander Bigger-AllenUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Hatim ThakerUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Hussein AttaUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
George LambrinosUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Kyle CostaUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Claire DoyleUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Mehrnaz Gharaee-KermaniCenter for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts, USA.
Susan PatalanoCenter for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts, USA.
Mary PiperHarvard Chan Bioinformatics Core, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Justin F CotellessaCenter for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts, USA.
Dijana VitkoUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Haiying LiUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Manubhai Kadayil PrabhakaranUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Vivian CristofaroDepartment of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
John FroehlichUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Richard S LeeUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.
Wei YangDepartment of Pathology, Stony Brook Medicine, Stony Brook University, Stony Brook, New York, USA.
Maryrose P SullivanDepartment of Surgery, Harvard Medical School, Boston, Massachusetts, USA.
Jill A MacoskaCenter for Personalized Cancer Therapy, University of Massachusetts, Boston, Massachusetts, USA.
Rosalyn M AdamUrological Diseases Research Center, Boston Children's Hospital, Boston, Massachusetts, USA.

Funding

MECHANOTRANSDUCTION IN BLADDER SMOOTH MUSCLER01DK077195 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ADAM, ROSALYN M · 2008 to 2018
$3.4M
NIMBLE: Non-Invasive Markers of Bladder DeteriorationR01DK127673 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI ADAM, ROSALYN M, LEE, RICHARD SANG-YONG · 2021 to 2025
$2.8M
Research Training in Pediatric Urology/CHB T32T32DK060442 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ADAM, ROSALYN M · 2002 to 2023
$2.5M
BLRD VA I01 BX001790NIDDK NIH HHS R01 DK077195NIDDK NIH HHS R01 DK127673NIDDK NIH HHS T32 DK060442
6 · The paper itself

Abstract

Spinal cord injury (SCI) evokes profound dysfunction in hollow organs such as the urinary bladder and gut. Current treatments are limited by a lack of molecular data to inform novel therapeutic avenues. Previously, we showed that systemic treatment with the neuroprotective agent inosine improved bladder function following SCI in rats. Here, we applied integrated multi-omics analysis to explore molecular alterations in the bladder over time and their sensitivity to inosine following SCI. Canonical signaling pathways regulated by SCI included those associated with protein synthesis, neuroplasticity, wound healing, and neurotransmitter degradation. Upstream regulator and causal network analysis predicted multiple effectors of DNA damage response signaling following injury, including poly-ADP ribose phosphorylase-1 (PARP1). Markers of DNA damage (γH2AX, ATM/ATR substrates) and PARP activity were increased in bladder tissue following SCI and attenuated with inosine treatment. Inosine treatment also attenuated oxidative DNA damage in rat bladder cells in vitro. Proteomics analysis suggested that SCI induced changes in protein synthesis-, neuroplasticity-, and oxidative stress-associated pathways, a subset of which were shown in transcriptomics data to be inosine sensitive. These findings provide insights into the molecular landscape of the bladder following SCI and identify key inosine-sensitive pathways associated with injury.

Indexed as

DNA DamageInosineSpinal Cord InjuriesUrinary Bladder, NeurogenicAnimalsDisease Models, AnimalFemaleMaleMultiomicsNeuroprotective AgentsOxidative StressProteomicsRatsRats, Sprague-DawleySignal TransductionUrinary BladderInosineNeuroprotective AgentsBioinformaticsCell biologyDNA repairMuscle biologyUrology

Identifiers

PMID40338665
PMCPMC12220959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.